-
-
-
-
-
-
-
Anavex withdraws EU marketing application for Alzheimer's drug
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Anavex Life Sciences (AVXL)
-
-
-
-
-
-
-
Anavex Life Sciences develops once-daily tablet for ANAVEX3-71 drug
-
-
-
-
-
-
-
Anavex Life Sciences (AVXL) Tops Q2 EPS by 2c
-
-
-
-
-
-
-
Anavex Life Sciences (AVXL) Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer’s Disease
-
-
-
-
-
-
-
EF Hutton Starts Anavex Life Sciences (AVXL) at Buy
-
448,177 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

